Last month in the Big Apple, tech companies in industries like logistics, pharmaceuticals, commerce and more secured notable capital raises. These companies plan to make investments across several fronts from scaling product innovation to growing geographically. Read on for more.
Top NYC Tech Funding Rounds, October 2023
- Headway
- CapitalRx
- Harri
- Prove Identity
- Transfix
#4. (tied) $40 million, October 19
Transfix pulled in a round of Series F funding led by New Enterprise Associates to support its path toward profitability. The company operates a machine learning-powered freight platform that aims to help enterprises operate with higher performance and reliability, drive long-term strategy and capacity planning while optimizing driver routes to avoid empty miles.
#4. (tied) $40 million, October 17
Prove’s identity verification solution leverages mobile phones to enable secure consumer experiences. The company raised a new round of funding co-led by MassMutual Ventures and Capital One Ventures to launch new commerce enablement and fraud-fighting use cases for its platform.
#3. $43 million, October 10
Harri closed out its Series B funding round at $43 million. The HR tech company offers talent attraction, workforce management, employee engagement and compliance solutions for organizations with frontline employees. Harri plans to fuel innovation, accelerate growth and scale to meet market demand.
#2. $50 million, October 11
Capital Rx works to improve drug price visibility and patient outcomes with its pharmacy benefit management platform, JUDI. The company raised a new investment round of more than $50 million that saw participation from several U.S. health systems. Capital Rx’s new funding will fuel R&D related to JUDI’s modules and capabilities, as well as growth across several internal teams including its member and client service departments.
#1. $125 million, October 5
Spark Capital led the latest round of venture funding for Headway, a healthtech company that connects patients to mental health professional within their insurance networks. The company is valued at $1 billion following its Series C investment. Headway will spend the fresh cash on expanding its network and increasing marketing with the goal of helping providers on the platform acquire patients.
